Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CTVA vs MRNA✓SelectedUSD · MRNACTVA vs MRNA performance historyLatest closeAs of-2.83%11/20
Stock and ETF performance explorer

CTVA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+15.9%
MRNA return
+153.9%
Excess return
-138.0%
Maximum drawdown
-45.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.8%-2.2%-0.7%-2.8%
7D-16.3%-12.7%-3.6%-16.0%
30D-38.0%-20.7%-17.3%-37.6%
3M-33.7%+46.3%-79.9%-34.3%
6M-33.0%+305.2%-338.2%-37.8%
YTD-21.0%+561.2%-582.3%-29.9%
1Y-17.6%+772.1%-789.6%-28.6%
3Y+15.9%+147.0%-131.1%+5.1%
All+15.9%+153.9%-138.0%+5.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling